Quantcast

Latest Ian M. Thompson Stories

2014-05-20 12:10:40

University of Texas Health Science Center at San Antonio Recruiting more Hispanics to cancer clinical trials crucial to reducing health disparities Hispanics are the fastest-growing demographic group in the United States, and they suffer from major health disparities, including higher rates of cancers of the cervix, stomach and liver. However, their enrollment levels in cancer clinical trials seeking to cure these problems is abysmally low: 3.9 percent. In a paper published today...

2013-09-23 13:06:32

Guideline provides detailed direction on treatment options for prostate cancer patients The American Society for Radiation Oncology (ASTRO) will highlight the recently published Adjuvant and Salvage Radiotherapy After Prostatectomy: ASTRO/AUA Guideline during ASTRO’s 55th Annual Meeting, September 22-25, 2013, in Atlanta. The guideline focuses on radiation therapy after prostatectomy for patients with and without evidence of prostate cancer recurrence, and is a joint effort between...

2013-08-15 11:55:34

A long-term follow-up to a groundbreaking study led by the director of the Cancer Therapy & Research Center confirms that a drug shown to reduce risk of prostate cancer by more than a third has no impact on lifespan but further reduces the risk of prostate cancer. Reducing the risk of prostate tumors by about 30 percent - and low-grade tumors by 43 percent - means thousands of men can avoid a cancer diagnosis and subsequent treatments that significantly affect quality of life, said Ian...

2013-04-04 12:16:56

Despite menopause-like side effects, continuous hormone treatment is superior to intermittent therapy A study published today in the New England Journal of Medicine recommends a dramatic shift in the way doctors treat metastatic prostate cancer. "These results have changed the way I treat patients," said Ian M. Thompson Jr., M.D., director of the Cancer Therapy & Research Center at The University of Texas Health Science Center at San Antonio and senior author on the international...

2012-08-24 00:19:47

Survival rate for African-American men now comparable to Caucasians, the Journal of Urology reports The routine use of prostate specific antigen (PSA) testing for screening and monitoring prostate cancer has led to early and more sensitive detection of the disease. A new study published in The Journal of Urology® reports that in the "PSA era," survival has improved for patients with newly diagnosed prostate cancer that has spread to the bones or other parts of the body and the...

2012-06-07 05:19:39

(Ivanhoe Newswire) — It has been said that 1 in every 6 men will develop prostate cancer during their lifetime. Second to skin cancer, prostate cancer is one of the most common cancers found in men today. Researchers have been constantly developing better therapies to treat the life threatening disease. New study results have just upended a decades-old prostate cancer therapy approach. Senior author of the long-term study Ian M. Thompson Jr., M.D., director of the Cancer Therapy...


Word of the Day
cruet
  • A vial or small glass bottle, especially one for holding vinegar, oil, etc.; a caster for liquids.
This word is Middle English in origin, and ultimately comes from the Old French, diminutive of 'crue,' flask.
Related